Product NDC: | 0703-1501 |
Proprietary Name: | Alprostadil |
Non Proprietary Name: | Alprostadil |
Active Ingredient(s): | 500 ug/mL & nbsp; Alprostadil |
Administration Route(s): | INTRAVASCULAR |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-1501 |
Labeler Name: | Teva Parenteral Medicines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075196 |
Marketing Category: | ANDA |
Start Marketing Date: | 19990430 |
Package NDC: | 0703-1501-02 |
Package Description: | 5 VIAL in 1 TRAY (0703-1501-02) > 1 mL in 1 VIAL (0703-1501-01) |
NDC Code | 0703-1501-02 |
Proprietary Name | Alprostadil |
Package Description | 5 VIAL in 1 TRAY (0703-1501-02) > 1 mL in 1 VIAL (0703-1501-01) |
Product NDC | 0703-1501 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Alprostadil |
Dosage Form Name | INJECTION |
Route Name | INTRAVASCULAR |
Start Marketing Date | 19990430 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc |
Substance Name | ALPROSTADIL |
Strength Number | 500 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE] |